Literature DB >> 24189511

Thyroid gland: Duration of intravenous glucocorticoid therapy in patients with Graves ophthalmopathy.

Claire Greenhill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24189511     DOI: 10.1038/nrendo.2013.224

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.

Authors:  Guia Vannucchi; Danila Covelli; Irene Campi; Daniele Origo; Nicola Currò; Valentina Cirello; Davide Dazzi; Paolo Beck-Peccoz; Mario Salvi
Journal:  Eur J Endocrinol       Date:  2013-11-22       Impact factor: 6.664

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.